Type A vs. Type B: Understanding the Different Botulinum Toxins
The botulinum toxin market is primarily dominated by Type A, but Type B also plays a vital role. This blog post explains the differences between these two types, their respective applications, and their market share. We will discuss why Type A is more widely used and how Type B serves a niche market, especially for patients who have developed resistance to Type A. To learn more about the product segmentation, check out the Botulinum Toxin Market report. Botulinum toxin type A, known by brand names like Botox and Dysport, is the most common and widely researched variant. It is approved for both a broad range of cosmetic and therapeutic uses. Botulinum toxin type B, on the other hand, is a distinct variant with a different mechanism of action. It is primarily used for therapeutic applications, such as cervical dystonia, particularly for patients who have developed immunity or a reduced response to Type A injections. This product segmentation ensures that the market can cater to a wider range of patient needs and therapeutic challenges.